Robyn Faye, MD, FACOG, MSCP, IF, CSC Medical Reviewer Robyn Faye, MD, is a board-certified ob-gyn with more than 35 years of clinical experience
GLP-1 receptor agonists: effects on cardiovascular risk reduction
Julio Rosenstock In ACHIEVE-3, researchers enrolled 1,698 adults with type 2 diabetes who were unable to maintain glycemic control with metformin, had an HbA1c of 7% to 10%, BMI of 25 kg/m 2 or higher, and less than 5% change in body weight in the 3 months before screening (mean age, 53.9 years
Clinical reviews have shown that this transmucosal route successfully bypasses the destructive enzymes of the GI tract and the liver's first-pass metabolism, resulting in a rapid and statistically significant increase in blood GSH concentrations
See how they work, their benefits, and side effects
Used for improving athletic performance and reducing muscle fatigue